Skip to main content
Erschienen in:

09.06.2020 | Melanoma

Sentinel Lymph Node Biopsy for Melanoma: Buggy Whip or Roller Bearing?

verfasst von: Giorgos C. Karakousis, MD, Mark B. Faries, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Excerpt

In July 1903, at the Mack Avenue assembly plant in Detroit, the first automobile produced by the Ford Motor Company rolled off the line. Across the country, suppliers to the horse and buggy industry, then a dominant form of personal transportation, were generally unaware of this significant event. In Westfield, Connecticut, for example, over 40 buggy whip manufacturers were hard at work, while in Ohio, the Timken Company was producing roller bearings for carriage wheels.1 Just over a century later, Timken remains an industrial giant, relevant in numerous industries, with products in everything from surgical robots to rovers cruising the surface of Mars. Buggy whips? Not so much. In melanoma oncology, the genomic revolution and advent of effective systemic therapies are our Model Ts. It seems reasonable to ponder where sentinel lymph node (SLN) biopsy will be as melanoma care evolves. Continued relevance of the technique will depend on two things: demonstration of ongoing value, and innovation. …
Literatur
1.
Zurück zum Zitat Stross R. Failing like a buggy whip maker? Better check your simile. NY Times, New York, 2010. Stross R. Failing like a buggy whip maker? Better check your simile. NY Times, New York, 2010.
2.
Zurück zum Zitat Dessureault S, Soong SJ, Ross MI, et al. Improved staging of node-negative patients with intermediate to thick melanomas (> 1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol. 2001;8:766–70.CrossRef Dessureault S, Soong SJ, Ross MI, et al. Improved staging of node-negative patients with intermediate to thick melanomas (> 1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol. 2001;8:766–70.CrossRef
3.
Zurück zum Zitat Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472–92. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472–92.
4.
Zurück zum Zitat Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609.CrossRef Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609.CrossRef
5.
Zurück zum Zitat Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976–83.CrossRef Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976–83.CrossRef
6.
Zurück zum Zitat Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.CrossRef Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.CrossRef
7.
Zurück zum Zitat McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004;86:212–23.CrossRef McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004;86:212–23.CrossRef
8.
Zurück zum Zitat Doubrovsky A, De Wilt JH, Scolyer RA, et al. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol. 2004;11:829–36.CrossRef Doubrovsky A, De Wilt JH, Scolyer RA, et al. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol. 2004;11:829–36.CrossRef
9.
Zurück zum Zitat Wright BE, Scheri RP, Ye X, et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg. 2008;143:892–9. discussion 899–900.CrossRef Wright BE, Scheri RP, Ye X, et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg. 2008;143:892–9. discussion 899–900.CrossRef
10.
Zurück zum Zitat Mozzillo N, Pennacchioli E, Gandini S, et al. Sentinel node biopsy in thin and thick melanoma. Ann Surg Oncol. 2013;20:2780–6.CrossRef Mozzillo N, Pennacchioli E, Gandini S, et al. Sentinel node biopsy in thin and thick melanoma. Ann Surg Oncol. 2013;20:2780–6.CrossRef
11.
Zurück zum Zitat Han D, Zager JS, Shyr Y, et al. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol. 2013;31:4387–93.CrossRef Han D, Zager JS, Shyr Y, et al. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol. 2013;31:4387–93.CrossRef
12.
Zurück zum Zitat Bello DM, Han G, Jackson L, et al. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma. Ann Surg Oncol. 2016;23:938–45.CrossRef Bello DM, Han G, Jackson L, et al. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma. Ann Surg Oncol. 2016;23:938–45.CrossRef
13.
Zurück zum Zitat Gyorki DE, Sanelli A, Herschtal A, et al. Sentinel lymph node biopsy in T4 melanoma: an important risk-stratification tool. Ann Surg Oncol. 2016;23:579–84.CrossRef Gyorki DE, Sanelli A, Herschtal A, et al. Sentinel lymph node biopsy in T4 melanoma: an important risk-stratification tool. Ann Surg Oncol. 2016;23:579–84.CrossRef
14.
Zurück zum Zitat Rondelli F, Vedovati MC, Becattini C, et al. Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. J Eur Acad Dermatol Venereol. 2012;26:560–5.CrossRef Rondelli F, Vedovati MC, Becattini C, et al. Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. J Eur Acad Dermatol Venereol. 2012;26:560–5.CrossRef
16.
Zurück zum Zitat Sinnamon AJ, Neuwirth MG, Song Y, Schultz SM, Liu S, Xu X, et al. Multispectral photoacoustic imaging for the detection of subclinical melanoma. J Surg Oncol. 2019;119(8):1070–76.CrossRef Sinnamon AJ, Neuwirth MG, Song Y, Schultz SM, Liu S, Xu X, et al. Multispectral photoacoustic imaging for the detection of subclinical melanoma. J Surg Oncol. 2019;119(8):1070–76.CrossRef
17.
Zurück zum Zitat Stoffels I, Morscher S, Helfrich I, et al. Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging. Sci Transl Med. 2015;7(317):317.CrossRef Stoffels I, Morscher S, Helfrich I, et al. Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging. Sci Transl Med. 2015;7(317):317.CrossRef
18.
Zurück zum Zitat Vetto JT, Hsueh EC, Gastman BR, et al. Guidance of sentinel lymph node biopsy decisions in patients with T1–T2 melanoma using gene expression profiling. Future Oncol. 2019;15:1207–17.CrossRef Vetto JT, Hsueh EC, Gastman BR, et al. Guidance of sentinel lymph node biopsy decisions in patients with T1–T2 melanoma using gene expression profiling. Future Oncol. 2019;15:1207–17.CrossRef
19.
Zurück zum Zitat Carvalho CEB, Capuzzo R, Crovador C, et al. Near infrared (NIR) fluorescence is not a substitute for lymphoscintigraphy and gamma probe for melanoma sentinel node detection: results from a prospective trial. Ann Surg Oncol. Epub 7 Apr 2020. http://doi.org/10.1245/s10434-020-08409-6. Carvalho CEB, Capuzzo R, Crovador C, et al. Near infrared (NIR) fluorescence is not a substitute for lymphoscintigraphy and gamma probe for melanoma sentinel node detection: results from a prospective trial. Ann Surg Oncol. Epub 7 Apr 2020. http://​doi.​org/​10.​1245/​s10434-020-08409-6.
20.
Zurück zum Zitat Voit CA, van Akkooi AC, Schafer-Hesterberg G, et al. Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol. 2009;27:4994–5000.CrossRef Voit CA, van Akkooi AC, Schafer-Hesterberg G, et al. Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol. 2009;27:4994–5000.CrossRef
21.
Zurück zum Zitat Cochran AJ, Wen DR, Huang RR, et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol. 2004;17:747–55.CrossRef Cochran AJ, Wen DR, Huang RR, et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol. 2004;17:747–55.CrossRef
22.
Zurück zum Zitat Santos-Juanes J, Fernandez-Vega I, Galache Osuna C, et al. Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2017;31:241–6. Santos-Juanes J, Fernandez-Vega I, Galache Osuna C, et al. Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2017;31:241–6.
23.
Zurück zum Zitat Hein DW, Moy RL. Elective lymph node dissection in stage I malignant melanoma: a meta-analysis. Melanoma Res. 1992;2:273–7.CrossRef Hein DW, Moy RL. Elective lymph node dissection in stage I malignant melanoma: a meta-analysis. Melanoma Res. 1992;2:273–7.CrossRef
24.
Zurück zum Zitat Lens MB, Dawes M, Goodacre T, et al. Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials. Arch Surg. 2002;137:458–61.PubMed Lens MB, Dawes M, Goodacre T, et al. Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials. Arch Surg. 2002;137:458–61.PubMed
25.
Zurück zum Zitat Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211–22.CrossRef Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211–22.CrossRef
Metadaten
Titel
Sentinel Lymph Node Biopsy for Melanoma: Buggy Whip or Roller Bearing?
verfasst von
Giorgos C. Karakousis, MD
Mark B. Faries, MD
Publikationsdatum
09.06.2020
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 8/2020
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08567-7

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" sprechen Prof. Dr. Leila Harhaus-Wähner und Ressortleiter Dr. Gunter Freese im WebTalk Leitlinie KOMPAKT, einer neuen Webcast-Serie von SpringerMedizin passend zu Ihrem Fachmagazin Orthopädie und Unfallchirurgie Mitteilungen und Nachrichten. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.